Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

DRG International, Inc.

US

Last updated September 17, 2026

Information

Country
US
Address
841 Mountain Ave, Springfield, NJ, 07081
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2245285
DUNS Number
—

Catalogue (212)

Page 4 of 5
DeviceModel / ReferenceRegistriesClassStatus
Thyrotropin (TSH) ELISA EIA-5283
FDA UDI
Class IIActive
Salivary Testosterone ELISA SLV-3013
FDA UDI
Class IActive
Lh Elisa EIA-4103
FDA UDI
Class IActive
Lh HYE-5362
FDA UDI
Class IActive
E. Histolytica IgG ELISA EIA-3474
FDA UDI
Class IIActive
Leptopspira IgG ELISA EIA-4245
FDA UDI
Class IIActive
Gliadin IgG ELISA EIA-3371
FDA UDI
Class IIUnknown
TSH Receptor Autoantibody ELISA EIA-3369
FDA UDI
Class IIActive
pANCA (MPO) ELISA EIA-3597
FDA UDI
Class IIActive
c-ANCA (PR3) ELISA EIA-3596
FDA UDI
Class IIUnknown
Free Testosterone ELISA EIA-4638
FDA UDI
Class IActive
Cotinine ELISA EIA-5917
FDA UDI
Class IActive
Mycoplasma pneumoniae IgG ELISA EIA-3499
FDA UDI
Class IActive
Androstenedione ELISA EIA-3265
FDA UDI
Class IActive
Anti TG Ab ELISA EIA-3708
FDA UDI
Class IIActive
Entamoeba histolytica IgG ELISA EIA-3830
FDA UDI
Class IIActive
Pregnenolone Direct ELISA EIA-4170
FDA UDI
Class IActive
Jo-1 IgG ELISA EIA-2787
FDA UDI
Class IIActive
Brucella IgG ELISA EIA-3455
FDA UDI
Class IIActive
Tgf-B1 Elisa EIA-1864
FDA UDI
Class IUnknown
Proteinase-3 IgG ELISA EIA-2778
FDA UDI
Class IIActive
Anti-SS-B ELISA EIA-3576
FDA UDI
Class IIActive
Estradiol Sensitive ELISA EIA-4399
FDA UDI
Class IActive
ANA-8-Screen ELISA EIA-3562
FDA UDI
Class IIActive
ENA-6-Profile ELISA EIA-3901
FDA UDI
Class IIActive
Ferritin ELISA EIA-1872
FDA UDI
Class IIUnknown
Sci-70 IgG ELISA EIA-2786
FDA UDI
Class IIActive
Prolactin HYE-5369
FDA UDI
Class IActive
Free Triiodothyronine (fT3) ELISA EIA-4107
FDA UDI
Class IIActive
Estradiol (serum) CLA-4664
FDA UDI
Class IActive
Fsh Elisa EIA-4098
FDA UDI
Class IActive
Legionella pneumophila IgG ELISA EIA-5645
FDA UDI
Class IIActive
Estradiol HYE-5349
FDA UDI
Class IActive
Anti-dsDNA IgG ELISA EIA-3438
FDA UDI
Class IIActive
Adenovirus Antigen (stool) ELISA EIA-3444
FDA UDI
Class IUnknown
Salivary Progesterone HS ELISA SLV-5911
FDA UDI
Class IActive
Candida albicans IgG ELISA EIA-3458
FDA UDI
Class IIActive
Cryptosporidium Antigen (stool) ELISA EIA-3467
FDA UDI
Class IIUnknown
Dengue Virus NS1 Ag ELISA EIA-6090
FDA UDI
Class IIActive
Anti-Jo-1 ELISA EIA-3581
FDA UDI
Class IIActive
Anti-Thyroid Peroxidase (Anti-TPO) ELISA EIA-4114
FDA UDI
Class IIActive
Estrone ELISA EIA-4079
FDA UDI
Class IActive
Leptospira IgG ELISA EIA-5751
FDA UDI
Class IIActive
Anti-dsDNA IgA ELISA EIA-3565
FDA UDI
Class IIUnknown
Progesterone (17-a-OH Progesterone) HYE-5333
FDA UDI
Class IActive
C-Reactive Protein HS ELISA EIA-3954
FDA UDI
Class IIActive
Total Triiodothyronine (tT3) ELISA EIA-5275
FDA UDI
Class IIActive
CMV IgG ELISA EIA-2797
FDA UDI
Class IIActive
Sm IgG ELISA EIA-2784
FDA UDI
Class IIActive
Salivary Progesterone ELISA SLV-2931
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (8)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Jun 4, 2025Z-2265-2025—open, classified

An incoming complaint reported that the expiration date on the kit box label and Certificate of Analysis (CoA) exceeded the shelf life of the standards and control solutions in the kit by 2 months (i.e., 2026-03-31 instead of 2026-01-31). The expiration dates on the bottle labels were correct (i.e., 2026-01-31).

Oct 7, 2024Z-0921-2025—open, classified

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Sep 13, 2024Z-0258-2025—open, classified

The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.

Jul 5, 2024Z-2622-2024—open, classified

Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.

Dec 21, 2021Z-0896-2022—terminated

ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible

Oct 18, 2021Z-0310-2022—open, classified

Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.

Nov 9, 2009Z-1068-2010—terminated

CHROMagar Products are labeled incorrectly. Label currently states that the product is for IVD use, when it should state that the product is intended For Research Use, Not for use in diagnostic procedures.

Nov 9, 2009Z-1067-2010—terminated

CHROMagar Products are labeled incorrectly. Label currently states that the product is for IVD use, when it should state that the product is intended For Research Use, Not for use in diagnostic procedures.